Cancer ResearchWhy Pancreatic Cancer Spreads So Aggressively and How New Models May Change That
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, largely because it is rarely caught before it has already spread. This review from researchers at NYU and Spain's CNIO synthesizes current knowledge on how metastatic PDAC behaves in patients, what molecular features make it so hard to treat, and how the tumor microenvironment — the ecosystem of cells and signals surrounding the tumor — actively assists its escape and spread to distant organs. The authors also catalog the preclinical models now available to study metastasis in the lab, from organoids to genetically engineered mice, and discuss where these tools fall short. The ultimate goal is to accelerate precision oncology strategies that can intercept metastasis earlier and more effectively than current chemotherapy regimens allow.
